NSC |
Compound |
Enrichment |
Correlation |
NSC 731701 |
1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate |
0.0135714101922724 |
0.10497495 |
NSC 733149 |
Null |
0.0135714101922724 |
0.4815462 |
NSC 750050 |
Null |
0.0135714101922724 |
0.073660984 |
NSC 752278 |
2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt |
0.0135714101922724 |
0.3393985 |
NSC 753456 |
2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole |
0.0135714101922724 |
0.57946376 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0139796580235792 |
0.39594234 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0139796580235792 |
0.22056432 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0139796580235792 |
0.45982874 |
NSC 244404 |
Null |
0.0139796580235792 |
0.41561466 |
NSC 30915 |
Null |
0.0139796580235792 |
0.36877826 |